Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.

Bancroft EK, Page EC, McHugh J, Thomas S, Taylor N, Pope J, Evans DG, Rothwell J, Grindedal EM, Maehle L, James P, McKinley J, Mascarenhas L, Side L, Thomas T, van Leerdam ME, van Asperen CJ, Kiemeney LALM, Ringelberg J, Vlaming M, Rønlund K, Osther PJS, Helfand BT, Hutten CG, Oldenburg RA, Cybulski C, Wokolorczyk D, Ong KR, Huber C, Salinas M, Feliubadaló L, Oosterwijk JC, van Zelst-Stams WAG, Cook J, Rosario DJ, Maxwell K, Powers J, Buys S, Lyman J, Ausems MGEM, Schmutzler RK, Rhiem K, Izatt L, Tripathi V, Teixeira MR, Cardoso M, Foulkes WD, Aprikian A, Davidson R, Longmuir M, Ruijs MWG, Blom EW, van Engelen K, Williams R, Andrews L, Murphy DG, Saya S, Halliday D, Walker L, Liljegren A, Carlsson S, Azzabi A, Jobson I, Snape K, Gowie M, Harris M, Tischkowitz M, Taylor A, Kirk J, Susman R, Chen-Shtoyerman R, Spigelman A, Pachter N, Ahmed M, Cajal TRY, Krajc M, Cleaver R, Cruellas M, Perez-Ballestero E, Brady AF, Gallagher D, Donaldson A, Barwell J, Nicolai N, Friedman E, Hall MJ, Greenhalgh L, Murthy V, Copakova L, McGrath JS, Cooke P, Arun B, Myhill K, Hogben M, Hussain S, Aaronson NK, Ardern-Jones A, Bangma CH, Castro E, Dearnaley D, Eccles DM, Tricker K, Falconer A, Gronberg H, Hamdy FC, Khoo V, Lilja H, Lindeman GJ, Lubinski J, Axcrona K, Mikropoulos C, Mitra A, Offman J, Rennert G, Suri M, Dudderidge T, IMPACT Study Collaborators, Brook MN, Kote-Jarai Z, Eeles RA

Open source

DOI
10.1016/j.eururo.2026.01.031
Published
2026 May
Container
European urology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.eururo.2026.01.031,
  title = {Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.},
  author = {Bancroft EK and Page EC and McHugh J and Thomas S and Taylor N and Pope J and Evans DG and Rothwell J and Grindedal EM and Maehle L and James P and McKinley J and Mascarenhas L and Side L and Thomas T and van Leerdam ME and van Asperen CJ and Kiemeney LALM and Ringelberg J and Vlaming M and Rønlund K and Osther PJS and Helfand BT and Hutten CG and Oldenburg RA and Cybulski C and Wokolorczyk D and Ong KR and Huber C and Salinas M and Feliubadaló L and Oosterwijk JC and van Zelst-Stams WAG and Cook J and Rosario DJ and Maxwell K and Powers J and Buys S and Lyman J and Ausems MGEM and Schmutzler RK and Rhiem K and Izatt L and Tripathi V and Teixeira MR and Cardoso M and Foulkes WD and Aprikian A and Davidson R and Longmuir M and Ruijs MWG and Blom EW and van Engelen K and Williams R and Andrews L and Murphy DG and Saya S and Halliday D and Walker L and Liljegren A and Carlsson S and Azzabi A and Jobson I and Snape K and Gowie M and Harris M and Tischkowitz M and Taylor A and Kirk J and Susman R and Chen-Shtoyerman R and Spigelman A and Pachter N and Ahmed M and Cajal TRY and Krajc M and Cleaver R and Cruellas M and Perez-Ballestero E and Brady AF and Gallagher D and Donaldson A and Barwell J and Nicolai N and Friedman E and Hall MJ and Greenhalgh L and Murthy V and Copakova L and McGrath JS and Cooke P and Arun B and Myhill K and Hogben M and Hussain S and Aaronson NK and Ardern-Jones A and Bangma CH and Castro E and Dearnaley D and Eccles DM and Tricker K and Falconer A and Gronberg H and Hamdy FC and Khoo V and Lilja H and Lindeman GJ and Lubinski J and Axcrona K and Mikropoulos C and Mitra A and Offman J and Rennert G and Suri M and Dudderidge T and IMPACT Study Collaborators and Brook MN and Kote-Jarai Z and Eeles RA},
  year = {2026},
  journal = {European urology},
  doi = {10.1016/j.eururo.2026.01.031},
  url = {https://doi.org/10.1016/j.eururo.2026.01.031}
}

RIS

TY  - JOUR
TI  - Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.
AU  - Bancroft EK
AU  - Page EC
AU  - McHugh J
AU  - Thomas S
AU  - Taylor N
AU  - Pope J
AU  - Evans DG
AU  - Rothwell J
AU  - Grindedal EM
AU  - Maehle L
AU  - James P
AU  - McKinley J
AU  - Mascarenhas L
AU  - Side L
AU  - Thomas T
AU  - van Leerdam ME
AU  - van Asperen CJ
AU  - Kiemeney LALM
AU  - Ringelberg J
AU  - Vlaming M
AU  - Rønlund K
AU  - Osther PJS
AU  - Helfand BT
AU  - Hutten CG
AU  - Oldenburg RA
AU  - Cybulski C
AU  - Wokolorczyk D
AU  - Ong KR
AU  - Huber C
AU  - Salinas M
AU  - Feliubadaló L
AU  - Oosterwijk JC
AU  - van Zelst-Stams WAG
AU  - Cook J
AU  - Rosario DJ
AU  - Maxwell K
AU  - Powers J
AU  - Buys S
AU  - Lyman J
AU  - Ausems MGEM
AU  - Schmutzler RK
AU  - Rhiem K
AU  - Izatt L
AU  - Tripathi V
AU  - Teixeira MR
AU  - Cardoso M
AU  - Foulkes WD
AU  - Aprikian A
AU  - Davidson R
AU  - Longmuir M
AU  - Ruijs MWG
AU  - Blom EW
AU  - van Engelen K
AU  - Williams R
AU  - Andrews L
AU  - Murphy DG
AU  - Saya S
AU  - Halliday D
AU  - Walker L
AU  - Liljegren A
AU  - Carlsson S
AU  - Azzabi A
AU  - Jobson I
AU  - Snape K
AU  - Gowie M
AU  - Harris M
AU  - Tischkowitz M
AU  - Taylor A
AU  - Kirk J
AU  - Susman R
AU  - Chen-Shtoyerman R
AU  - Spigelman A
AU  - Pachter N
AU  - Ahmed M
AU  - Cajal TRY
AU  - Krajc M
AU  - Cleaver R
AU  - Cruellas M
AU  - Perez-Ballestero E
AU  - Brady AF
AU  - Gallagher D
AU  - Donaldson A
AU  - Barwell J
AU  - Nicolai N
AU  - Friedman E
AU  - Hall MJ
AU  - Greenhalgh L
AU  - Murthy V
AU  - Copakova L
AU  - McGrath JS
AU  - Cooke P
AU  - Arun B
AU  - Myhill K
AU  - Hogben M
AU  - Hussain S
AU  - Aaronson NK
AU  - Ardern-Jones A
AU  - Bangma CH
AU  - Castro E
AU  - Dearnaley D
AU  - Eccles DM
AU  - Tricker K
AU  - Falconer A
AU  - Gronberg H
AU  - Hamdy FC
AU  - Khoo V
AU  - Lilja H
AU  - Lindeman GJ
AU  - Lubinski J
AU  - Axcrona K
AU  - Mikropoulos C
AU  - Mitra A
AU  - Offman J
AU  - Rennert G
AU  - Suri M
AU  - Dudderidge T
AU  - IMPACT Study Collaborators
AU  - Brook MN
AU  - Kote-Jarai Z
AU  - Eeles RA
PY  - 2026
JO  - European urology
DO  - 10.1016/j.eururo.2026.01.031
UR  - https://doi.org/10.1016/j.eururo.2026.01.031
ER  - 

APA

EK, B., EC, P., J, M., S, T., N, T., J, P., DG, E., J, R., EM, G., L, M., P, J., J, M., L, M., L, S., T, T., ME, V. L., CJ, V. A., LALM, K., J, R., M, V., K, R., PJS, O., BT, H., CG, H., RA, O., C, C., D, W., KR, O., C, H., M, S., L, F., JC, O., WAG, V. Z., J, C., DJ, R., K, M., J, P., S, B., J, L., MGEM, A., RK, S., K, R., L, I., V, T., MR, T., M, C., WD, F., A, A., R, D., M, L., MWG, R., EW, B., K, V. E., R, W., L, A., DG, M., S, S., D, H., L, W., A, L., S, C., A, A., I, J., K, S., M, G., M, H., M, T., A, T., J, K., R, S., R, C., A, S., N, P., M, A., TRY, C., M, K., R, C., M, C., E, P., AF, B., D, G., A, D., J, B., N, N., E, F., MJ, H., L, G., V, M., L, C., JS, M., P, C., B, A., K, M., M, H., S, H., NK, A., A, A., CH, B., E, C., D, D., DM, E., K, T., A, F., H, G., FC, H., V, K., H, L., GJ, L., J, L., K, A., C, M., A, M., J, O., G, R., M, S., T, D., Collaborators, I. S., MN, B., Z, K., & RA, E. (2026). Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.. European urology. https://doi.org/10.1016/j.eururo.2026.01.031

Source records